JPRN-UMIN000007836
Completed
Phase 2
Phase II study of palliative radiotherapy combined with Zoledronic Acid Hydrate for metastatic bone tumor from renal cell carcinoma - Phase II study of Zometa+RT for bone metastasis from RCC
Shizuoka Cancer Center Japanese Radiation Oncology Study Group0 sites30 target enrollmentApril 25, 2012
ConditionsRenal cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Renal cancer
- Sponsor
- Shizuoka Cancer Center Japanese Radiation Oncology Study Group
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Surgery is needed for bone metastasis 2\)Hypercalcemia 3\)Dental problem
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A phase II study of combination of radiotherapy and Atezolizumab/nab-paclitaxel for inoperable or recurrent PD-L1 positive triple negative breast cancerinoperable or recurrent PD-L1 positive triple negative breast cancerJPRN-jRCTs021210010Suzuki Yoshiyuki20
Active, Not Recruiting
Phase 1
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable high grade gliomas patientsEUCTR2016-003468-38-FRCentre François baclesse
Completed
N/A
Phase I trial evaluating combined radiotherapy with Panitumumab (Vectibix®) in patients with muscle invasive transitional cell carcinoma of the bladderbladder cancerBladder carcinoma10004994NL-OMON34833Antoni van Leeuwenhoek Ziekenhuis31
Recruiting
Phase 2
Phase II study of chemoradiotherapy combined with gemcitabine and nab-paclitaxel for unresectable locally advanced pancreatic cancernresectable locally advanced pancreatic cancerJPRN-UMIN000028116agoya University Pancreatic Tumor Bord25
Recruiting
Phase 1
Phase I study for simultaneous radiochemotherapy of relapsed ovarian cancerC51-C58Malignant neoplasms of female genital organsDRKS00008552niversitätsklinikum für Strahlentherapie6